Michael A. Byrne
Direttore Finanziario/CFO presso Viventia Biotech, Inc.
Posizioni attive di Michael A. Byrne
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Direttore Finanziario/CFO | 01/01/2000 | - |
| Segretario Aziendale | 01/01/2000 | - |
Storia della carriera di Michael A. Byrne
Precedenti posizioni note di Michael A. Byrne
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Hyal Pharmaceutical Corp. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Canada | 3 |
Posizioni
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
| Hyal Pharmaceutical Corp. | Health Technology |
- Borsa valori
- Insiders
- Michael A. Byrne
- Esperienza
